CancerSpeak: An American Cancer Society Journals Podcast

Introducing CancerSpeak, the official podcast of Cancer, a journal of the American Cancer Society. CancerSpeak is dedicated to bringing the best of science to the broadest audiences, offering the latest research, real-life stories, and expert perspectives from the field of oncology.

CancerSpeak: An American Cancer Society Journals Podcast is a health podcast hosted by ACS Journal Cancer, with 24 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

ACS Journal Cancer hosts CancerSpeak: An American Cancer Society Journals Podcast, a health show with 24 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #24

  Optimizing Asparaginase and Blinatumomab in Frontline Acute Lymphoblastic Leukemia

  Aug 11, 202611 min

  What are the latest recommendations for frontline acute lymphoblastic leukemia (ALL) treatment? In this episode of CancerSpeak, Cancer Hematologic Malignancies Section Editor Dr. Courtney DiNardo is joined by Dr. Daniel DeAngelo and Dr. David McCall to discuss a new international expert consensus statement on optimizing the safety and efficacy of asparaginase and blinatumomab in frontline ALL treatment. They walk through the key recommendations from the consensus statement, exploring how these therapies fit into modern treatment approaches and what clinicians should consider when applying these strategies across different healthcare settings. Read the full consensus statement in Cancer: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70559 Follow Cancer on social media: x.com/JournalCancer instagram.com/acsjournals linkedin.com/company/acs-journals Original music by J. Gilman.

  ListenShow Notes
• 

  Episode #23

  Top Advances of the Year: Palliative and Supportive Care in Oncology

  Jul 13, 202622 min

  Palliative and supportive care helps reduce suffering, manage symptoms, and improve quality of life for people living with cancer, yet many patients still face barriers to accessing these services. Recent advances are helping address these challenges, from new evidence on the impact of telehealth and electronic patient-reported outcomes to emerging approaches for cancer cachexia. In this episode of CancerSpeak, Cancer Deputy Editor and Breast Disease Section Editor Dr. Ruth O'Regan speaks with Dr. Carrie Sha, Dr. Andrew Epstein, and Dr. Yael Schenker about the year’s most notable developments in palliative and supportive care in oncology, the challenges that remain, and how these advances may translate into better support for patients with cancer and their caregivers. Read the accompanying commentary in Cancer: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70392 Follow Cancer on social media: x.com/JournalCancer instagram.com/acsjournals linkedin.com/company/acs-journals Original music by J. Gilman

  ListenShow Notes
• 

  Episode #22

  Post-MPN AML: Real-World Outcomes and Ongoing Challenges

  Jun 23, 202614 min

  Have newer therapies improved outcomes for patients with acute myeloid leukemia after myeloproliferative neoplasms, or post-MPN AML? In this episode of CancerSpeak, Cancer Hematologic Malignancies Section Editor Dr. Courtney DiNardo is joined by Dr. Jan Philipp Bewersdorf and Dr. Anand Patel to discuss an article in Cancer evaluating real-world outcomes among patients with post-MPN AML in the United States. Their conversation explores survival trends in the era of novel therapies, barriers to allogeneic hematopoietic cell transplantation, and future directions for improving outcomes in this rare, high-risk disease. Read the accompanying article in Cancer: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70415 Follow Cancer on social media: x.com/JournalCancer instagram.com/acsjournals linkedin.com/company/acs-journals Original music by J. Gilman.

  ListenShow Notes
• 

  Episode #21

  Antibody–Drug Conjugates: Clinical Perspectives from Europe

  Jun 2, 202622 minS0

  <p>Dr. Daniel Morgensztern, Section Editor of Chest and Lung Disease for the journal Cancer, is joined by Dr. Emiliano Calvo and Dr. André Mansinho to discuss a new supplement in Cancer focused on recent advances in antibody–drug conjugates (ADCs). Their conversation covers the main mechanisms of resistance and action, key considerations for oncologists related to toxicities, and the evolving outlook for ADCs, including next-generation strategies and their role in clinical practice.</p> <p>Read the supplement in Cancer: https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2026/132/S1</p> <p>Follow Cancer on social media:<br> x.com/JournalCancer<br> instagram.com...

  ListenShow Notes
• 

  Episode #20

  A New Home for Pediatric and AYA Oncology Research

  May 19, 202614 minS0

  <p>In this episode of CancerSpeak, Dr. Nirali Shah is joined by Dr. William Dahut, Chief Scientific Officer of the American Cancer Society, and Dr. Suresh Ramalingam, Editor-in-Chief of Cancer, to discuss the launch of Pediatric, Adolescent & Young Adult Cancer, a new open-access, multidisciplinary journal from the American Cancer Society.</p> <p>As inaugural Editor-in-Chief of the new journal, Dr. Shah leads a conversation exploring the current landscape of pediatric and adolescent and young adult (AYA) oncology research, the ongoing gaps and challenges across the field, and why a dedicated new publication focused on these populations is both timely and...

  ListenShow Notes

Recent guests on CancerSpeak: An American Cancer Society Journals Podcast. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.